HealthLynked Corp. Completes Reverse Stock Split to Strengthen Market Position and Support Growth Initiatives
TL;DR
HealthLynked's reverse stock split strengthens its capital structure and positions the company for potential uplisting, offering investors a strategic advantage in healthcare technology growth.
The non-dilutive reverse stock split reduces outstanding shares and increases per-share price while preserving shareholder ownership to improve market positioning.
HealthLynked's AI healthcare guide and telemedicine platform improve patient outcomes and reduce costs through better care coordination and accessible medical records.
HealthLynked launched its patented AI healthcare guide ARi and is expanding nationwide telemedicine services while negotiating with major insurance carriers.
Found this article helpful?
Share it with your network and spread the knowledge!

HealthLynked Corp. (OTCQB: HLYK) has completed a reverse stock split as part of its strategic initiative to strengthen its capital structure and improve market positioning. This non-dilutive corporate action reduces the number of outstanding shares while increasing the per-share price, aligning with the expectations of institutional investors and national trading platforms. The move supports potential uplisting opportunities while preserving existing shareholder ownership percentages.
The reverse stock split coincides with HealthLynked's recent launch of ARi, its patented AI healthcare guide, and the continued expansion of its nationwide telemedicine platform and digital services. The company's cloud-based platform connects patients with healthcare providers for both virtual and in-office appointments while consolidating medical records into a single secure, accessible location. This integrated approach enhances personalized care management, improves health outcomes, and reduces healthcare costs through AI-driven insights and coordinated care solutions.
HealthLynked is currently engaged in discussions with major insurance carriers to integrate its technology into care management workflows, a development that could position the company for scalable recurring revenue growth. The platform's enterprise partnership capabilities offer scalable solutions to healthcare networks and digital health innovators, providing substantial savings on prescriptions and healthcare services while empowering both patients and providers through advanced digital tools.
Additional information about HealthLynked's developments and corporate updates is available in the company's newsroom at https://ibn.fm/HLYLK. The completion of the reverse stock split represents a significant milestone in HealthLynked's growth strategy, potentially enhancing the company's appeal to institutional investors and facilitating access to broader capital markets while supporting the expansion of its innovative healthcare technology platform.
Curated from InvestorBrandNetwork (IBN)
